Literature DB >> 16868855

Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation.

Shintaro Kiuchi1, Kunihiko Teraoka, Kiyoshi Koizumi, Kenji Takazawa, Akira Yamashina.   

Abstract

We report a case in which late gadolinium enhancement (LGE) and 67-Ga scintigraphy were useful for the diagnosis of cardiac sarcoidosis and for the evaluation of the disease activity. The patient was a 60-year-old woman who had been diagnosed as having eye sarcoidosis when she was 48. Two years previously her electrocardiogram had shown abnormalities but the coronary angiography had shown normal coronary arteries; however, an aneurysm was detected in the apical portion by left ventriculography. A II degree AV block was noted on the electrocardiogram and she was referred to us for further detailed evaluation. Since the biopsy findings of skin eruptions on both eyelids indicated an epithelial cell granuloma, she was diagnosed as having cutaneous sarcoidosis. On the 67-Ga scintigram, myocardial accumulation of gallium was recognized, and on cardiovascular magnetic resonance (CMR), LGE was recognized. She was diagnosed as cardiac sarcoidosis and steroid therapy started with 30 mg prednisolone. The myocardial accumulation of gallium on the 67-Ga scintigram disappeared after the 30th day of steroid therapy. On the other hand, no changes in LGE patterns were seen after steroid therapy. In this case, LGE was useful for the diagnosis of cardiac sarcoidosis, and 67-Ga scintigram was useful for the evaluation of the disease activity. This case shows that both imaging techniques are important for the diagnosis of cardiac sarcoidosis and evaluation of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868855     DOI: 10.1007/s10554-006-9134-3

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  19 in total

1.  Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging.

Authors:  Joaquín J Serra; Guilherme U Monte; Evandro S Mello; Gabriela P Coral; Luiz F R Avila; José R Parga; José A F Ramires; Carlos E Rochitte
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

Review 2.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

3.  An improved MR imaging technique for the visualization of myocardial infarction.

Authors:  O P Simonetti; R J Kim; D S Fieno; H B Hillenbrand; E Wu; J M Bundy; J P Finn; R M Judd
Journal:  Radiology       Date:  2001-01       Impact factor: 11.105

Review 4.  Cardiac and neurologic dysfunction in sarcoidosis.

Authors:  O P Sharma
Journal:  Clin Chest Med       Date:  1997-12       Impact factor: 2.878

5.  The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis.

Authors:  Jan-Peter Smedema; Gabriel Snoep; Marinus P G van Kroonenburgh; Robert-Jan van Geuns; Emiel C Cheriex; Anton P M Gorgels; Harry J G M Crijns
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

6.  Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.

Authors:  T Shimada; K Shimada; T Sakane; K Ochiai; H Tsukihashi; M Fukui; S Inoue; H Katoh; Y Murakami; Y Ishibashi; R Maruyama
Journal:  Am J Med       Date:  2001-05       Impact factor: 4.965

7.  Racial difference in cardiac sarcoidosis incidence observed at autopsy.

Authors:  K Iwai; M Sekiguti; Y Hosoda; R A DeRemee; H D Tazelaar; O P Sharma; A Maheshwari; T I Noguchi
Journal:  Sarcoidosis       Date:  1994-03

8.  Cardiac sarcoidosis detected by delayed-hyperenhancement magnetic resonance imaging.

Authors:  Margit A Nemeth; Raja Muthupillai; James M Wilson; Mukta Awasthi; Scott D Flamm
Journal:  Tex Heart Inst J       Date:  2004

9.  Clinicopathological study of fatal myocardial sarcoidosis.

Authors:  Y Matsui; K Iwai; T Tachibana; T Fruie; N Shigematsu; T Izumi; A H Homma; R Mikami; O Hongo; Y Hiraga; M Yamamoto
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

10.  Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.

Authors:  K J Silverman; G M Hutchins; B H Bulkley
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

View more
  5 in total

Review 1.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

2.  Left ventricular apical aneurysm due to unrecognized sarcoidosis.

Authors:  Tomizo Masuno; Kumiko Hirata; Nozomi Wada; Haruka Endo; Kazushi Takemoto; Tsuyoshi Nishiguchi; Ikuko Teraguchi; Naoki Maniwa; Aiko Shimokado; Manabu Kashiwagi; Hiroto Tsujioka; Hideyuki Ikejima; Akio Kuroi; Kohei Ishibashi; Kenichi Komukai; Takashi Tanimoto; Yasushi Ino; Hironori Kitabata; Keizo Kimura; Toshio Imanishi; Takashi Akasaka
Journal:  J Echocardiogr       Date:  2010-06-04

Review 3.  ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Keiichiro Yoshinaga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

Review 4.  Advanced imaging of cardiac sarcoidosis.

Authors:  Chadi Ayoub; Elena Pena; Hiroshi Ohira; Alexander Dick; Eugene Leung; Pablo B Nery; David Birnie; Rob S B Beanlands
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

5.  Cardiac sarcoidosis: diagnosis and management.

Authors:  Michelle Bussinguer; Alfred Danielian; Om P Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.